Halia Therapeuticsto Participate in the 6th Annual Needham Private Biotech & MedTech Company Virtual 1x1 Forum
<p>LEHI, Utah, Oct. 7, 2026 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class therapies targeting inflammasome-driven disease biology, today announced that the Company plans to participate in the 6th Annual Needham Private Biotech...</p>
Read original article ↗
Related Articles
SAN LUIS OBISPO, Calif., Oct. 7, 2026 /PRNewswire/ -- Gateworks Corporation, an Ezurio company, today announces the GW16
Enhance Power Quality with a GaN-based AC/DC Three-Level Vienna Rectifier
Data centers have become essential to almost every part of the global economy with the continuing rise in computing dema
The formation of working groups focused on Physical AI, Security, and Interoperability marks a new era in edge AI, empha
Benekiva Introduces Kiva, an AI-Enabled Claims Assistant Built to Support Claims Professionals
Embedded guidance helps examiners identify missing information and know what needs attention next DES MOINES, Iowa, Oct.